Recently, Bayard et al. firstly described the recurrent fusion of the CCNA2 gene in the non-cirrhotic liver cancer genome, which leads to oncogene activation by truncating a regulatory N-terminal domain [36]. This evidence concerns the gene CCNA2 and liver cancer.